Literature DB >> 31642924

Trends in Internet Searches for Cannabidiol (CBD) in the United States.

Eric C Leas1, Alicia L Nobles2, Theodore L Caputi3, Mark Dredze4, Davey M Smith2, John W Ayers2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31642924      PMCID: PMC6820034          DOI: 10.1001/jamanetworkopen.2019.13853

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

Cannabidiol (CBD) is widely promoted as a panacea. For example, the cannabis brand MedMen claims CBD treats acne, anxiety, opioid addiction, pain, and menstrual problems.[1] However, the US Food and Drug Administration has only approved highly purified CBD (Epidiolex) for treating epilepsy. To our knowledge, there is currently no population-focused surveillance of public interest in CBD. Consequently, many question whether CBD should be prioritized by public health leaders and regulators. This article describes public interest in CBD within the United States.

Methods

In this longitudinal cross-sectional study, we measured Google searches that mentioned “CBD” or “cannabidiol” emerging from the United States (including by state) from January 1, 2004, through April 23, 2019. We report these measurements as query fractions (QFs), which are the number of searches per every 10 million searches originating nationally or from a respective state. We forecasted searches through 2019 using an autoregressive integrated moving average model, with components estimated using the algorithm developed by Hyndman and Khandakar[2] and data from all months since 2014. This model is robust to time series biases such as recurring periodicities. We also contrasted search volumes during April 2019 for CBD against those for several health topics, products, or alternative medicines, including acupuncture, apple cider vinegar, diet (excluding “Coke” or “Pepsi”), electronic cigarettes (“e cig/s,” “e cigarette/s,” “electronic cigarette/s,” “vape,” “vaping,” or “vapor,” excluding “marijuana” or “cannabis”), exercise, marijuana (“marijuana” or “cannabis”), meditation, vaccines (“vaccine/s,” “vaccinate/d,” or “vaccination”), veganism, and yoga. Raw search counts were inferred using estimates from the media measurement and analytics company Comscore. Analyses were performed using R statistical software version 3.5.2 (R Project for Statistical Computing) and followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for cross-sectional studies. Ethical review by the institutional review board was not required per 45 CFR part 46 and the standard operating policies and procedures at the University of California, San Diego, which do not require review of studies that do not involve intervention or interaction with individuals and use information that is not individually identifiable.

Results

Nationally, CBD searches were stable from 2004 through 2014 but then substantially increased (Figure 1). Search volumes increased 125.9% during 2017 compared with 2016, 160.4% during 2018 compared with 2017, and are expected to be 117.7% (95% prediction interval, 99.5%-135.6%) higher during 2019 than 2018 based on observed and forecasted volumes. There were 6.4 million CBD Google searches during April 2019, the last month data were collected.
Figure 1.

National and State Google Searches for Cannabidiol or CBD Since 2014

Forecasts were projected through 2019 using the forecasting algorithm developed by Hyndman and Khandakar.[2]

National and State Google Searches for Cannabidiol or CBD Since 2014

Forecasts were projected through 2019 using the forecasting algorithm developed by Hyndman and Khandakar.[2] The increase in CBD searches encompassed all states, ranging from a 211.2% increase (2014-2018 to 2019) in Oklahoma to a 605.0% increase in Alabama. During 2019 (January to April), Vermont (QF = 7164.1), Wisconsin (QF = 6120.6), Tennessee (QF = 6096.2), Colorado (QF = 5815.5), New Hampshire (QF = 5391.4), and Oregon (QF = 5369.2) had the most searches. Searches were higher during 2019 in states that had legalized recreational marijuana (mean [SD] QF = 4975.6 [814.0]) than in states with medicinal marijuana (mean [SD] QF = 4451.9 [609.7]) or marijuana prohibitions (mean [SD] QF = 4560.9 [964.0]). Searches for CBD during April 2019 eclipsed those for acupuncture by a factor of 7.49, apple cider vinegar by 5.17, meditation by 3.38, vaccination by 1.63, exercise by 1.59, marijuana by 1.13, and veganism by 1.12 (Figure 2). Searches for CBD are now rivaling searches for yoga and electronic cigarettes, with 0.96 and 0.85 of their respective search volumes, and are searched for more than half as much as dieting (0.51).
Figure 2.

Google Searches for Cannabidiol or CBD and for Other Health Topics in April 2019

Comparison of April 2019 Google searches that included the terms cannabidiol or CBD with searches including terms for other health topics. Specific lists of queries are given in the Methods section. e-Cigarettes indicates electronic cigarettes.

Google Searches for Cannabidiol or CBD and for Other Health Topics in April 2019

Comparison of April 2019 Google searches that included the terms cannabidiol or CBD with searches including terms for other health topics. Specific lists of queries are given in the Methods section. e-Cigarettes indicates electronic cigarettes.

Discussion

The findings of this longitudinal cross-sectional study indicate that interest in CBD across the United States has increased considerably and is accelerating. While our study is limited in that Google searches may reflect interest in CBD rather than interest in use, search trends are associated with many health-related behaviors,[3] including the rise of electronic cigarettes,[4] years ahead of traditional data. Thus, our findings suggest that investigation into CBD should become a public health priority to catch up with the public’s interest. First, studies should focus on the epidemiology of CBD use, characterizing who uses CBD products and for what purposes. Second, the effects and potential drug interactions of CBD should be evaluated. Third, given that CBD products are often mislabeled[5] and adulterated products have led to mass poisonings,[6] product safety standards must be developed. Fourth, marketing practices around CBD should be standardized, as marketing that misleads the public could erode trust in evidence-based medicine.
  5 in total

1.  The Need for Federal Regulation of Marijuana Marketing.

Authors:  John W Ayers; Theodore L Caputi; Eric C Leas
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

2.  Labeling Accuracy of Cannabidiol Extracts Sold Online.

Authors:  Marcel O Bonn-Miller; Mallory J E Loflin; Brian F Thomas; Jahan P Marcu; Travis Hyke; Ryan Vandrey
Journal:  JAMA       Date:  2017-11-07       Impact factor: 56.272

3.  Tracking the rise in popularity of electronic nicotine delivery systems (electronic cigarettes) using search query surveillance.

Authors:  John W Ayers; Kurt M Ribisl; John S Brownstein
Journal:  Am J Prev Med       Date:  2011-04       Impact factor: 5.043

4.  The Charlie Sheen Effect on Rapid In-home Human Immunodeficiency Virus Test Sales.

Authors:  Jon-Patrick Allem; Eric C Leas; Theodore L Caputi; Mark Dredze; Benjamin M Althouse; Seth M Noar; John W Ayers
Journal:  Prev Sci       Date:  2017-07

5.  Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol - Utah, 2017-2018.

Authors:  Roberta Z Horth; Barbara Crouch; B Zane Horowitz; Amelia Prebish; Matthew Slawson; Jennifer McNair; Chris Elsholz; Stephen Gilley; Jenny Robertson; Ilene Risk; Mary Hill; Linnea Fletcher; Wei Hou; Dallin Peterson; Karlee Adams; Dagmar Vitek; Allyn Nakashima; Angela Dunn
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-05-25       Impact factor: 17.586

  5 in total
  18 in total

1.  THC and CBD blood and brain concentrations following daily administration to adolescent primates.

Authors:  S L Withey; J Bergman; M A Huestis; S R George; B K Madras
Journal:  Drug Alcohol Depend       Date:  2020-06-18       Impact factor: 4.492

2.  Therapeutic Claims in Cannabidiol (CBD) Marketing Messages on Twitter.

Authors:  Mohammad Soleymanpour; Sofia Saderholm; Ramakanth Kavuluru
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2022-01-14

3.  Development and initial psychometric properties of the Cannabidiol Outcome Expectancies Questionnaire (CBD-OEQ).

Authors:  Katherine Walukevich-Dienst; Paige E Morris; Raymond P Tucker; Amy L Copeland; Julia D Buckner
Journal:  Psychol Assess       Date:  2022-03-17

4.  Cannabidiol (CBD) Oil, Cancer, and Symptom Management: A Google Trends Analysis of Public Interest.

Authors:  Santhosshi Narayanan; Felippe Lazar Neto; Kimberson Tanco; Gabriel Lopez; Wenli Liu; Eduardo Bruera; Vivek Subbiah
Journal:  J Altern Complement Med       Date:  2020-01-22       Impact factor: 2.579

5.  Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.

Authors:  Corneliu N Stanciu; Mary F Brunette; Nikhil Teja; Alan J Budney
Journal:  Psychiatr Serv       Date:  2021-02-03       Impact factor: 3.084

6.  Public interest in ∆8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆9-Tetrahydrocannabinol (delta-9-THC) use.

Authors:  Eric C Leas; Alicia L Nobles; Yuyan Shi; Erik Hendrickson
Journal:  Int J Drug Policy       Date:  2021-12-21

7.  A Warning against the Negligent Use of Cannabidiol in Professional and Amateur Athletes.

Authors:  Dirk W Lachenmeier; Patrick Diel
Journal:  Sports (Basel)       Date:  2019-12-14

8.  Cannabidiol Product Dosing and Decision-Making in a National Survey of Individuals with Fibromyalgia.

Authors:  Kevin F Boehnke; Joel J Gagnier; Lynne Matallana; David A Williams
Journal:  J Pain       Date:  2021-06-30       Impact factor: 5.820

9.  Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.

Authors:  Ekaterina V Fedorova; Carolyn F Wong; Janna Ataiants; Ellen Iverson; Bridgid M Conn; Stephen E Lankenau
Journal:  Drug Alcohol Depend       Date:  2021-02-22       Impact factor: 4.492

10.  Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops.

Authors:  Eric C Leas; Natalie Moy; Sara B McMenamin; Yuyan Shi; Tarik Benmarhnia; Matthew D Stone; Dennis R Trinidad; Martha White
Journal:  Int J Environ Res Public Health       Date:  2021-06-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.